Kiniksa Pharmaceuticals International, plc has grown revenue 47% a year over three years and 105% a year over five, with earnings per share compounding at −31%. Revenue growth, 3-year annual rate: +47% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +105%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −31%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 9, FY2017 to FY2025, as filed.

KNSAKiniksa Pharmaceuticals International, plc

Healthcare

$79.76+125% 1Y

$79.76

$35.5152 weeks$80.83

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +57% year on year and operating margin widening (+16.1 points), but earnings down −464% year on year.

2 good, 1 to watch

Revenue trend+57% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend−464% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+16.1 points operating

Trailing-twelve-month operating margin, 12.4% now against -3.7% a year earlier.

All from SEC EDGAR, as of Mar 31, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is KNSA growing?

Kiniksa Pharmaceuticals International, plc has grown revenue 47% a year over three years and 105% a year over five, with earnings per share compounding at −31%.

+47%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +105%
Revenue growth, 5-year rate · +47% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −31%
Earnings per share, 3-year rate · revenue +47% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed